| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |